DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.

Published in: Journal of translational medicine (2022)

DEPTH2 is expected to have a wider spectrum of applications in evaluating ITH in comparison to other algorithms.

Keyphrases